Related references
Note: Only part of the references are listed.Biochemical Activity of Vaborbactam
Ruslan Tsivkovski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Kinetic Profile and Molecular Dynamic Studies Show that Y229W Substitution in an NDM-1/L209F Variant Restores the Hydrolytic Activity of the Enzyme toward Penicillins, Cephalosporins, and Carbapenems
Alessandra Piccirilli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Will morphing boron-based inhibitors beat the β-lactamases?
Alen Krajnc et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases
Alen Krajnc et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa
Jodie C. Hamrick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
A Kinetic Study of the Replacement by Site Saturation Mutagenesis of Residue 119 in NDM-1 Metallo-β-Lactamase
Francesca Marcoccia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Past and Present Perspectives on β-Lactamases
Karen Bush
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae
Meredith A. Hackel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms
Elizabeth Temkin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Interaction of Avibactam with Class B Metallo-β-Lactamases
Martine I. Abboud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism
HongMin Zhang et al.
FASEB JOURNAL (2011)
Share Paper
